Tag: biosimilars
Navigating Insurance Formulary Changes and Generic Switching in 2026
Navigate 2026 insurance formulary updates and generic switching. Learn how the IRA $2,000 cap affects costs, how to file exceptions, and manage biosimilar transitions.
Biosimilars and Pharmacist Counseling: How Pharmacists Guide Patients and Handle Substitution
Biologics make up just 2% of prescriptions but half of drug spending. Biosimilars can save costs, but pharmacists play a key role in counseling patients and handling substitutions. Learn how they overcome barriers like patient hesitancy and prescriber resistance.